Devyser Diagnostics Management
Management criteria checks 4/4
Devyser Diagnostics' CEO is Fredrik Dahl, appointed in Jan 2025, has a tenure of less than a year. directly owns 0.21% of the company’s shares, worth €354.30K. The average tenure of the management team and the board of directors is 2.6 years and 4.3 years respectively.
Key information
Fredrik Dahl
Chief executive officer
SEK 200.0k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | 0.2% |
| Management average tenure | 2.6yrs |
| Board average tenure | 4.3yrs |
Recent management updates
Recent updates
CEO
Fredrik Dahl (47 yo)
less than a year
Tenure
SEK 200,000
Compensation
Dr. Fredrik Dahl, PhD, serves as Director at Devyser Diagnostics AB (publ) since 2021 and as its Interim CEO since January 2025. He is Partner of Colibri Ventures Ab. Dr. Dahl serves as the Chief Technolog...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Interim CEO & Director | less than a year | SEK 200.00k | 0.21% € 354.3k | |
| Chief Financial Officer | 4.3yrs | no data | no data | |
| Chief Scientific Officer | 2.3yrs | no data | no data | |
| Chief Human Resource Officer | 2.7yrs | no data | no data | |
| Chief Commercial Officer | 2.9yrs | no data | no data | |
| VP & GM of Devyser US | 2.5yrs | no data | no data |
2.6yrs
Average Tenure
45yo
Average Age
Experienced Management: OL0's management team is considered experienced (2.6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Interim CEO & Director | 4.3yrs | SEK 200.00k | 0.21% € 354.3k | |
| Director | 9.3yrs | SEK 200.00k | no data | |
| Independent Director | 3.7yrs | SEK 200.00k | 0.015% € 25.4k | |
| Chairman | 15.3yrs | SEK 400.00k | 24.42% € 41.9m | |
| Independent Director | 1yr | SEK 100.00k | no data |
4.3yrs
Average Tenure
57yo
Average Age
Experienced Board: OL0's board of directors are considered experienced (4.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/11 03:08 |
| End of Day Share Price | 2025/05/09 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Devyser Diagnostics AB (publ) is covered by 5 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Erik Hultgård | Carnegie Investment Bank AB |
| Ludvig Lundgren | Nordea Markets |
| Filip Wiberg | Pareto Securities |